流通市值:43.88亿 | 总市值:62.12亿 | ||
流通股本:6536.66万 | 总股本:9253.53万 |
报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
一、经营活动产生的现金流量: | ||||
销售商品、提供劳务收到的现金 | 682,086,093.28 | 309,950,530.24 | 1,307,791,135.16 | 968,999,553.41 |
收到的税费返还 | - | - | - | 1,084.95 |
收到其他与经营活动有关的现金 | 8,672,832.38 | 4,404,590.62 | 26,479,845.17 | 14,091,478.81 |
经营活动现金流入小计 | 690,758,925.66 | 314,355,120.86 | 1,334,270,980.33 | 983,092,117.17 |
购买商品、接受劳务支付的现金 | 180,869,409.13 | 86,066,160.93 | 385,846,358.14 | 288,605,785.19 |
支付给职工以及为职工支付的现金 | 257,188,336.63 | 132,832,510.48 | 409,344,327.42 | 308,153,118.51 |
支付的各项税费 | 20,042,465.86 | 7,815,559.73 | 48,313,600.03 | 36,498,815.53 |
支付其他与经营活动有关的现金 | 219,647,471.25 | 94,471,840.43 | 310,521,297.38 | 206,605,695.16 |
经营活动现金流出小计 | 677,747,682.87 | 321,186,071.57 | 1,154,025,582.97 | 839,863,414.39 |
经营活动产生的现金流量净额 | 13,011,242.79 | -6,830,950.71 | 180,245,397.36 | 143,228,702.78 |
二、投资活动产生的现金流量: | ||||
取得投资收益收到的现金 | 1,020,767.9 | 898,432.52 | 10,123,894.34 | 8,227,925.4 |
处置固定资产、无形资产和其他长期资产收回的现金净额 | 583,117.51 | 484.28 | 581,630.96 | 815,652.97 |
收到的其他与投资活动有关的现金 | 1,061,000,000 | 906,000,000 | 3,581,147,440.28 | 3,014,049,493.96 |
投资活动现金流入小计 | 1,062,603,885.41 | 906,898,916.8 | 3,591,852,965.58 | 3,023,093,072.33 |
购建固定资产、无形资产和其他长期资产支付的现金 | 81,615,163.18 | 46,882,397.8 | 150,398,624.4 | 121,014,188.61 |
支付其他与投资活动有关的现金 | 884,000,000 | 714,000,000 | 3,431,049,493.96 | 2,678,049,493.96 |
投资活动现金流出小计 | 965,615,163.18 | 760,882,397.8 | 3,581,448,118.36 | 2,799,063,682.57 |
投资活动产生的现金流量净额 | 96,988,722.23 | 146,016,519 | 10,404,847.22 | 224,029,389.76 |
三、筹资活动产生的现金流量: | ||||
吸收投资收到的现金 | 18,428,800 | 6,400,000 | 3,443,740 | 3,293,740 |
其中:子公司吸收少数股东投资收到的现金 | - | 6,400,000 | 3,443,740 | 3,293,740 |
取得借款收到的现金 | 21,848,420.21 | 9,548,420.21 | 7,440,130 | 7,440,130 |
收到其他与筹资活动有关的现金 | - | - | 50,110,114.75 | - |
筹资活动现金流入小计 | 40,277,220.21 | 15,948,420.21 | 60,993,984.75 | 10,733,870 |
偿还债务支付的现金 | 7,440,130 | 6,350,130 | - | - |
分配股利、利润或偿付利息支付的现金 | 37,193,477.49 | 41,817.95 | 78,354,708.38 | 78,245,865.11 |
其中:子公司支付给少数股东的股利、利润 | - | - | 1,520,000 | 1,260,000 |
支付其他与筹资活动有关的现金 | 14,554,468.9 | 7,095,869.23 | 100,341,140.48 | 41,652,697.21 |
筹资活动现金流出小计 | 59,188,076.39 | 13,487,817.18 | 178,695,848.86 | 119,898,562.32 |
筹资活动产生的现金流量净额 | -18,910,856.18 | 2,460,603.03 | -117,701,864.11 | -109,164,692.32 |
四、汇率变动对现金及现金等价物的影响 | -283,674.89 | -252,340.12 | -114,615.29 | -959,909.06 |
五、现金及现金等价物净增加额 | 90,805,433.95 | 141,393,831.2 | 72,833,765.18 | 257,133,491.16 |
加:期初现金及现金等价物余额 | 564,805,779.67 | 564,805,779.67 | 491,972,014.49 | 491,972,014.49 |
期末现金及现金等价物余额 | 655,611,213.62 | 706,199,610.87 | 564,805,779.67 | 749,105,505.65 |
补充资料: | ||||
净利润 | 47,880,718.46 | - | 88,654,186.07 | - |
资产减值准备 | 8,492,867.33 | - | 4,318,208.69 | - |
固定资产和投资性房地产折旧 | 3,489,682 | - | 5,981,837.07 | - |
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 3,489,682 | - | 5,981,837.07 | - |
无形资产摊销 | 689,732.54 | - | 1,318,944.52 | - |
长期待摊费用摊销 | 7,984,316.07 | - | 8,107,895.28 | - |
处置固定资产、无形资产和其他长期资产的损失 | -583,117.51 | - | -814,569.57 | - |
公允价值变动损失 | -827,790.47 | - | -220,096.27 | - |
财务费用 | 2,009,805.39 | - | 1,766,386.38 | - |
投资损失 | -3,843,601.83 | - | -23,976,662.04 | - |
递延所得税 | -1,666,492.26 | - | 4,570,250.69 | - |
其中:递延所得税资产减少 | -1,498,455.86 | - | 5,064,254.9 | - |
递延所得税负债增加 | -168,036.4 | - | -494,004.21 | - |
存货的减少 | 2,900,863.06 | - | -3,864,470.39 | - |
经营性应收项目的减少 | -73,205,968.11 | - | 801,957.2 | - |
经营性应付项目的增加 | 4,856,034.49 | - | 67,850,462.66 | - |
其他 | 0 | - | 224,159.91 | - |
现金的期末余额 | 655,611,213.62 | - | 564,805,779.67 | - |
减:现金的期初余额 | 564,805,779.67 | - | 491,972,014.49 | - |
现金及现金等价物的净增加额 | 90,805,433.95 | - | 72,833,765.18 | - |
公告日期 | 2025-08-29 | 2025-04-29 | 2025-04-29 | 2024-10-29 |
审计意见(境内) | 标准无保留意见 |